II 

118TH CONGRESS 

1ST SESSION S. 2922 

To advance population research for chronic pain. 

IN THE SENATE OF THE UNITED STATES 

SEPTEMBER 26 (legislative day, SEPTEMBER 22), 2023 

Mr. CASEY (for himself, Mrs. BLACKBURN, Mr. KAINE, and Mr. CRAMER) introduced the following bill; which was read twice and referred to the Committee on Health, Education, Labor, and Pensions 

A BILL 

To advance population research for chronic pain. 

1 Be it enacted by the Senate and House of Representa2 tives of the United States of America in Congress assembled, 

3 SECTION 1. SHORT TITLE. 

4 This Act may be cited as the ‘‘Advancing Research 

5 for Chronic Pain Act of 2023’’. 

6 SEC. 2. NATIONAL CHRONIC PAIN INFORMATION SYSTEM. 

7 Part P of title III of the Public Health Service Act 

8 (42 U.S.C. 280g et seq.) is amended by adding at the end 

9 the following: 


kjohnson on DSK7ZCZBW3PROD with $$_JOB
2 

•S 2922 IS

1 ‘‘SEC. 399V–8. CHRONIC PAIN RESEARCH. 

2 ‘‘(a) IN GENERAL.—The Secretary, acting through 

3 the Director of the Centers for Disease Control and Pre4 vention in consultation with the Director of the National 

5 Center for Injury Prevention and Control and the Director 

6 of the National Center for Chronic Disease Prevention and 

7 Health Promotion, and in coordination with the NIH 

8 Helping to End Addiction Long-term Initiative and with 

9 other agencies as the Secretary determines appropriate, 

10 shall— 

11 ‘‘(1) utilize available Federal research data to 

12 clarify the incidence and prevalence of chronic pain 

13 from any source, including injuries, operations, and 

14 diseases and conditions; 

15 ‘‘(2) identify gaps in the available research data 

16 and collect deidentified population research data 

17 using medical claims and survey data to fill gaps in 

18 available research data, such as information con19 cerning— 

20 ‘‘(A) incidence and prevalence of specific 

21 pain conditions; 

22 ‘‘(B) demographics and other information, 

23 such as age, race, ethnicity, gender, and geo24 graphic location; 

25 ‘‘(C) the incidence and prevalence of 

26 known chronic pain conditions, as well as of 


kjohnson on DSK7ZCZBW3PROD with $$_JOB
3 

•S 2922 IS

1 diseases and conditions that include or lead to 

2 pain; 

3 ‘‘(D) risk factors that may be associated 

4 with chronic pain conditions, such as genetic 

5 and environmental risk factors and other infor6 mation, as appropriate; 

7 ‘‘(E) diagnosis and progression markers; 

8 ‘‘(F) both direct and indirect costs of ill9 ness; 

10 ‘‘(G) the epidemiology of the conditions; 

11 ‘‘(H) the detection, management, and 

12 treatment of the conditions; 

13 ‘‘(I) the epidemiology, detection, manage14 ment, and treatment of frequent secondary or 

15 co-occurring conditions, such as depressive, anx16 iety, and substance use disorders; 

17 ‘‘(J) the utilization of medical and social 

18 services by patients with chronic pain condi19 tions, including the direct health care costs of 

20 pain treatment, both traditional and alternative, 

21 and the indirect costs (such as missed work, 

22 public and private disability, and reduction in 

23 productivity); and 


kjohnson on DSK7ZCZBW3PROD with $$_JOB
4 

•S 2922 IS

1 ‘‘(K) the effectiveness of evidence-based 

2 treatment approaches on chronic pain condi3 tions; 

4 ‘‘(3) develop, in collaboration with individuals 

5 and organizations with appropriate chronic pain ex6 pertise, including patients or patient advocates, epi7 demiologists, representatives of national voluntary 

8 health associations, health information technology 

9 experts, clinicians, and research scientists, standard 

10 definitions and approaches for population research 

11 on chronic pain to efficiently promote greater com12 parability of data; and 

13 ‘‘(4) disseminate, pursuant to the public 

14 webpage under subsection (b), and, as appropriate, 

15 to the public and to other Federal departments and 

16 agencies, any findings, developed population research 

17 standards, and available Federal data sources re18 lated to chronic pain. 

19 ‘‘(b) DISSEMINATION.—The Secretary, acting 

20 through the Director of the Centers for Disease Control 

21 and Prevention, shall establish a public webpage, to be 

22 known as the Chronic Pain Information Hub, that— 

23 ‘‘(1) aggregates and summarizes available Fed24 eral data sources, indicators, and peer-reviewed re25 search related to chronic pain; 


kjohnson on DSK7ZCZBW3PROD with $$_JOB
5 

•S 2922 IS

1 ‘‘(2) includes an up-to-date summary of com2 plete, underway, and planned data collection and 

3 analysis related to chronic pain that is conducted 

4 and supported by the Centers for Disease Control 

5 and Prevention; and 

6 ‘‘(3) translates research findings into clinical 

7 tools and resources, recommendations for closing re8 search gaps, and recommendations for population re9 search standards for researchers, with recommenda10 tions updated annually to incorporate research find11 ings from the prior year. 

12 ‘‘(c) CONFLICTS OF INTEREST.—If an individual or 

13 organization that collaborates with the Secretary in car14 rying out subsection (a) receives a payment or other trans15 fer of value of a type described in section 

16 1128G(a)(1)(A)(vi) of the Social Security Act from a man17 ufacturer of a drug (including a biological product) or de18 vice that would be required to be disclosed pursuant to 

19 section 1128G(a)(1) of the Social Security Act, if the indi20 vidual or organization were a covered recipient or if such 

21 disclosure were required upon request of or by designation 

22 on behalf of a covered recipient pursuant to such section, 

23 the individual or organization shall disclose to the Sec24 retary information regarding such payment or other transVerDate Sep 11 2014 01:52 Sep 27, 2023 Jkt 039200 PO 00000 Frm 00005 Fmt 6652 Sfmt 6201 E:\BILLS\S2922.IS S2922

kjohnson on DSK7ZCZBW3PROD with $$_JOB
6 

•S 2922 IS

1 fer of value. The Secretary shall make such disclosures 

2 publicly available. 

3 ‘‘(d) REPORT.—Not later than 2 years after the date 

4 of the enactment of the Advancing Research for Chronic 

5 Pain Act of 2023, the Secretary shall submit a report to 

6 Congress concerning the implementation of this section. 

7 Such report shall include information on— 

8 ‘‘(1) the development and maintenance of the 

9 Chronic Pain Information Hub; 

10 ‘‘(2) the information made available through 

11 the Chronic Pain Information Hub; 

12 ‘‘(3) the data gaps identified, and planned ef13 forts to address such gaps; 

14 ‘‘(4) the process established for soliciting feed15 back from collaborators; and 

16 ‘‘(5) feedback received from collaborators. 

17 ‘‘(e) DEFINITION.—In this section, the term ‘chronic 

18 pain’ means persistent or recurrent pain lasting longer 

19 than 3 months. 

20 ‘‘(f) AUTHORIZATION OF APPROPRIATIONS.—To 

21 carry out this section, there is authorized to be appro22 priated such sums as may be necessary for each of fiscal 

23 years 2024 through 2028.’’. 

Æ 


kjohnson on DSK7ZCZBW3PROD with $$_JOB